D, S., Y, L., E, S., G, G., M, D., AC, O., . . . DL, Q. (2026). Effect of liraglutide on subclinical atherosclerosis and cardiometabolic risk factors in adults with type 1 diabetes: A prospective pilot study. Diabetic medicine : a journal of the British Diabetic Association, 43(4), e70222. https://doi.org/10.1111/dme.70222
Chicago Style (17th ed.) CitationD, Sánchez-García, et al. "Effect of Liraglutide on Subclinical Atherosclerosis and Cardiometabolic Risk Factors in Adults with Type 1 Diabetes: A Prospective Pilot Study." Diabetic Medicine : A Journal of the British Diabetic Association 43, no. 4 (2026): e70222. https://doi.org/10.1111/dme.70222.
MLA (9th ed.) CitationD, Sánchez-García, et al. "Effect of Liraglutide on Subclinical Atherosclerosis and Cardiometabolic Risk Factors in Adults with Type 1 Diabetes: A Prospective Pilot Study." Diabetic Medicine : A Journal of the British Diabetic Association, vol. 43, no. 4, 2026, p. e70222, https://doi.org/10.1111/dme.70222.